Hybio Pharmaceutical Co., Ltd. (SZSE:300199) said controlling shareholder and party acting in concert plan to unload up to 2% stake in the company within six months.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.77 CNY | -8.03% |
|
-0.74% | -20.69% |
May. 29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
May. 29 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
1st Jan change | Capi. | |
---|---|---|
-20.69% | 1.42B | |
+18.81% | 42.12B | |
+24.77% | 21.72B | |
+20.96% | 14.89B | |
+56.50% | 13.06B | |
-0.05% | 6.79B | |
-11.78% | 6.3B | |
+17.73% | 6.05B | |
-8.87% | 5.73B | |
+6.11% | 4.58B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharma's Controlling Shareholder and Party Acting in Concert Plan to Unload Stake